Teicoplanin

• Catalog No.: Bio-0102
• CAS Number: 61036-62-2
• M. F.: C90H101Cl2N9O31
• M. W.: 1875.71264

SYNONYMS

• IUPAC name: (1R,18R,19S,22S,34R,37R,40S,53R)-53-amino-5,15-dichloro-64-{[(1R,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(8-methylnonanamido)cyclohexyl]oxy}-18-{[(2R,3R,4R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-25,30,43,48-tetrahydroxy-20,36,39,54,56,59-hexaoxo-27-{[(1R,2S,3S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy}-7,13,46-trioxa-21,35,38,55,57,60-hexaazaundecacyclo[38.15.2.2^3,^6.2^1^4,^1^7.2^1^9,^3^4.1^8,^1^2.1^2^9,^3^3.1^4^1,^4^5.0^1^0,^3^7.0^2^3,^2^8.0^4^7,^5^2]hexahexaconta-3,5,8,10,12(64),14,16,23(28),24,26,29(61),30,32,41(58),42,44,47(52),48,50,62,65-henicosaene-22-carboxylic acid
• IUPAC Traditional name: (1R,18R,19S,22S,34R,37R,40S,53R)-53-amino-5,15-dichloro-64-{[(1R,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(8-methylnonanamido)cyclohexyl]oxy}-18-{[(2R,3R,4R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-25,30,43,48-tetrahydroxy-20,36,39,54,56,59-hexaoxo-27-{[(1R,2S,3S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy}-7,13,46-trioxa-21,35,38,55,57,60-hexaazaundecacyclo[38.15.2.2^3,^6.2^1^4,^1^7.2^1^9,^3^4.1^8,^1^2.1^2^9,^3^3.1^4^1,^4^5.0^1^0,^3^7.0^2^3,^2^8.0^4^7,^5^2]hexahexaconta-3,5,8,10,12(64),14,16,23(28),24,26,29(61),30,32,41(58),42,44,47(52),48,50,62,65-henicosaene-22-carboxylic acid
• Synonyms: Targocid

DATABASE IDS

• CAS Number: 61036-62-2

PROPERTIES

• Application(s): Antibiotic
• Application(s): Highly active against staphylococci and gram-positive anaerobes
• Biological Source: Isol. from Actinoplanes teichomyceticus
• Description: Teicoplanin A2 1-5
• Mechanism of Action: Inhibitor of bacterial cell wall synthesis

REFERENCES

• Ger. Pat., 1976, Gruppo Lepetit, 2 608 216; CA, 86, 3563x, (isol)
• Bardone, M.R. et al., J. Antibiot., 1978, 31, 170, (isol, props, uv, ir)
• Parenti, F. et al., J. Antibiot., 1978, 31, 276, (isol, props)
• Pallanza, R. et al., J. Antimicrob. Chemother., 1983, 11, 94; 419, (props)
• Borghi, A. et al., J. Antibiot., 1984, 37, 615; 1989, 42, 361, (isol, struct, bibl)
• Malabaric, J.C. et al., J. Antibiot., 1984, 37, 988, (struct)
• Williams, A.H. et al., J. Antimicrob. Chemother., 1984, 14, 441, (rev, pharmacol)
• Barna, J.C.J. et al., J.A.C.S., 1984, 106, 4895, (pmr, cmr, struct)
• Pryka, R.D. et al., Clin. Pharm., 1988, 7, 647, (rev)
• Campoli-Richards, D.M. et al., Drugs, 1990, 40, 449, (rev)
• Parenti, F. et al., Fortschr. Antimikrob. Antineoplast. Chemother., 1991, 10, 105; 111, (rev)
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 211
• Brogden, R.N. et al., Drugs, 1994, 47, 823, (rev)
• Goldstein, B.P. et al., Glycopept. Antibiot., (Ed. Nagarajan, R.), M. Dekker, 1994, 273-307, (rev)
• Trautmann, M. et al., Infection (Munich), 1994, 22, 430, (rev)
• McMullin, C.M. et al., J. Antimicrob. Chemother., 1994, 34, 425, (hplc)
• Heydorn, A. et al., J. Biol. Chem., 2000, 275, 6201-6206, (biosynth)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, TAI400